These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 28365054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An overview of the new frontiers in the treatment of atherogenic dyslipidemias.
    Rached FH, Chapman MJ, Kontush A.
    Clin Pharmacol Ther; 2014 Jul; 96(1):57-63. PubMed ID: 24727469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD, Fazio S.
    Circ Res; 2016 Feb 19; 118(4):732-49. PubMed ID: 26892970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipid-lowering agents.
    Ewang-Emukowhate M, Wierzbicki AS.
    J Cardiovasc Pharmacol Ther; 2013 Sep 19; 18(5):401-11. PubMed ID: 23811423
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in pharmacotherapy for hypertriglyceridemia.
    Sahebkar A, Chew GT, Watts GF.
    Prog Lipid Res; 2014 Oct 19; 56():47-66. PubMed ID: 25083925
    [Abstract] [Full Text] [Related]

  • 10. Novel strategies for managing dyslipidemia: treatment beyond statins.
    Ling H, Burns TL, Hilleman DE.
    Postgrad Med; 2012 Nov 19; 124(6):43-54. PubMed ID: 23322138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia.
    Wiggins BS.
    J Cardiovasc Pharmacol; 2021 Nov 01; 78(5):e631-e640. PubMed ID: 34738550
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D, Pöss J, Böhm M, Laufs U.
    J Am Coll Cardiol; 2013 Oct 15; 62(16):1401-8. PubMed ID: 23973703
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.